OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
Hilary A. Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 31, pp. 3613-3622
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Human malignancies associated with persistent HPV infection
Alison A. McBride
The Oncologist (2024) Vol. 29, Iss. 6, pp. 457-464
Open Access | Times Cited: 7

Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Gypsyamber D’Souza, Sakshi R. Tewari, Tanya Troy, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 4, pp. 516-524
Open Access | Times Cited: 5

Epidemiologie und Prävention des Oropharynxkarzinoms
Andreas Dietz
HNO (2025)
Closed Access

Circulating tumor HPV DNA, antibodies to HPV16 early proteins, and oral HPV16 DNA as biomarkers for HPV-related oropharyngeal cancer screening
Kristina R. Dahlstrom, Andrew T. Day, Víctor Asensi, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 1
Closed Access

Screening for oropharyngeal cancer: the time is Now
Kristina R. Dahlstrom, Erich M. Sturgis, Karen S. Anderson
Expert Review of Molecular Diagnostics (2025)
Closed Access

Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology – A proof-of-concept study
Chia‐Jung Busch, Anna Sophie Hoffmann, Daniele Viarisio, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101659-101659
Open Access | Times Cited: 19

Prevention and control of HPV-related cancers in people living with HIV
Anneli Uusküla, Anna Tisler, Jack DeHovitz, et al.
The Lancet HIV (2025)
Closed Access

Development of a multiplexed lateral flow assay for the serologic detection of HPV-associated head and neck cancer
Ching‐Wen Hou, Pankaj Kumar, Stacy Williams, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 2
Closed Access

Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study
Gypsyamber D’Souza, Sakshi R. Tewari, Tanya Troy, et al.
Cancer (2023) Vol. 129, Iss. 15, pp. 2373-2384
Open Access | Times Cited: 10

The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer
Jacob P. Conarty, Andreas Wieland
Viruses (2023) Vol. 15, Iss. 6, pp. 1296-1296
Open Access | Times Cited: 9

The relation between human papillomavirus (HPV) and oropharyngeal cancer: a review
Chrystiano de Campos Ferreira
PeerJ (2023) Vol. 11, pp. e15568-e15568
Open Access | Times Cited: 9

Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study
Sana Batool, Rosh K.V. Sethi, Annette Wang, et al.
Oral Oncology (2023) Vol. 147, pp. 106584-106584
Open Access | Times Cited: 9

Blood-based screening for HPV-associated cancers
Dipon Das, Shun Hirayama, Ling Aye, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Update: Epidemiologie und Prävention des Oropharynxkarzinoms
Andreas Dietz, Gunnar Wichmann, Susanne Wiegand, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103, Iss. 04, pp. 296-313
Closed Access | Times Cited: 3

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma
Tomokazu Yoshizaki, Satoru Kondo, Hirotomo Dochi, et al.
Microorganisms (2023) Vol. 12, Iss. 1, pp. 14-14
Open Access | Times Cited: 8

Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis
Eleni M. Rettig, Tim Waterboer, Edward S. Sim, et al.
Oral Oncology (2023) Vol. 141, pp. 106417-106417
Closed Access | Times Cited: 6

Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?
Philip E. Castle
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 4, pp. 349-351
Open Access | Times Cited: 3

Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers
Charles Lacey
Tumour Virus Research (2023) Vol. 15, pp. 200250-200250
Open Access | Times Cited: 2

Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models
Jeya Balaji Balasubramanian, Parichoy Pal Choudhury, Srijon Mukhopadhyay, et al.
JAMIA Open (2024) Vol. 7, Iss. 2
Open Access

Natural history of HPV16-E6 serology among cancer-free men in a multicenter longitudinal cohort study
Jaimie Z. Shing, Anna R. Giuliano, N. Brenner, et al.
JNCI Journal of the National Cancer Institute (2024)
Closed Access

Nouveaux marqueurs développés pour le dépistage des cancers liés aux HPV
Valentine Marie Ferré, Julie Brousseau, Charlotte Charpentier, et al.
Revue Francophone des Laboratoires (2024) Vol. 2024, Iss. 558, pp. 46-58
Open Access

Epidemiologie und Prävention des Oropharynxkarzinoms
Andreas Dietz
Deleted Journal (2024) Vol. 30, Iss. 7, pp. 631-642
Closed Access

Current Status of Vaccine of Human Papillomavirus-positive Patients with Oropharyngeal Carcinoma
Mohan Bansal
NMO journal (2024) Vol. 18, Iss. 1, pp. 18-21
Closed Access

Page 1 - Next Page

Scroll to top